ClearPoint Neuro
CLPT
63 hedge funds and large institutions have $29.8M invested in ClearPoint Neuro in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 8 closing their positions.
793% more call options, than puts
Call options by funds: $545K | Put options by funds: $61K
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
33% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 12
5% more funds holding
Funds holding: 60 → 63 (+3)
0.5% more ownership
Funds ownership: 23.63% → 24.13% (+0.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
29% less capital invested
Capital invested by funds: $42M → $29.8M (-$12.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TFCM
Taylor Frigon Capital Management
Scottsdale,
Arizona
|
+$639K |
| 2 |
LG
Lane Generational
Dover,
Massachusetts
|
+$613K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$399K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$332K |
| 5 |
Morgan Stanley
New York
|
+$293K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$290K |
| 2 |
Millennium Management
New York
|
-$257K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$191K |
| 4 |
D.E. Shaw & Co
New York
|
-$188K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$139K |
CLPT Hedge Fund Activity: Q3 2023 in Review
63 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2023, worth a combined $29.8M — down 29% from $42M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new CLPT positions and 8 closed out — a net gain of 4 holders — while 16 added to existing stakes and 12 trimmed.
The largest buyer was Taylor Frigon Capital Management, adding an estimated $639K. The largest seller was Wells Fargo, cutting an estimated $290K.
- 63 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2023, up from 60 in Q2 2023.
- Funds reported $29.8M of ClearPoint Neuro stock for Q3 2023, down 29% quarter-over-quarter.
- 12 funds opened new ClearPoint Neuro positions in Q3 2023 and 8 closed out, a net change of +4 holders.
- The largest ClearPoint Neuro buyer in Q3 2023 was Taylor Frigon Capital Management, an estimated $639K added.
- The largest ClearPoint Neuro seller in Q3 2023 was Wells Fargo, an estimated $290K sold.
Based on aggregated 13F filings for Q3 2023.